SGA
Sector Gamma AS Portfolio holdings
AUM
$306M
This Quarter Return
+6.19%
1 Year Return
+4.68%
3 Year Return
+19.67%
5 Year Return
+46.47%
10 Year Return
+161.43%
AUM
$602M
AUM Growth
+$602M
(+8.4%)
Cap. Flow
+$7.84M
Cap. Flow
% of AUM
1.3%
Top 10 Holdings %
Top 10 Hldgs %
66.65%
Holding
35
New
5
Increased
14
Reduced
12
Closed
3
Top Buys
| 1 |
Bristol-Myers Squibb
BMY
|
$29.9M |
| 2 |
Gilead Sciences
GILD
|
$13.3M |
| 3 |
Merck
MRK
|
$11.4M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
$9.83M |
| 5 |
Ultragenyx Pharmaceutical
RARE
|
$5.23M |
Top Sells
| 1 |
Tenet Healthcare
THC
|
$14.9M |
| 2 |
Ironwood Pharmaceuticals
IRWD
|
$13.3M |
| 3 |
AGN
Allergan plc
AGN
|
$10.8M |
| 4 |
Boston Scientific
BSX
|
$9.16M |
| 5 |
Eli Lilly
LLY
|
$6.05M |
Sector Composition
| 1 | Healthcare | 98.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
Ultragenyx Pharmaceutical
RARE
$2.89B
| $5.23M | 0.87% |
+68,015
| New | +$5.23M |
|
27
Alnylam Pharmaceuticals
ALNY
$58.5B
| $3.2M | 0.53% |
+32,500
| New | +$3.2M |
|
|
28
Tenet Healthcare
THC
$16.3B
| $3.04M | 0.5% |
90,503
-443,518
| -83% | -$14.9M |
|
|
BLUE
29
DELISTED
bluebird bio
BLUE
| $2.67M | 0.44% |
+17,000
| New | +$2.67M |
|
|
ONCE
30
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| $2.62M | 0.43% |
31,600
-15,000
| -32% | -$1.24M |
|
31
Sangamo Therapeutics
SGMO
$157M
| $2.07M | 0.34% |
146,000
+50,000
| +52% | +$710K |
|
32
Regenxbio
RGNX
$451M
| $718K | 0.12% |
+10,000
| New | +$718K |
|
33
Agios Pharmaceuticals
AGIO
$2.19B
| – | – |
-41,000
| Closed | -$3.35M |
|
34
Sarepta Therapeutics
SRPT
$1.78B
| – | – |
-51,006
| Closed | -$3.78M |
|
|
AGN
35
DELISTED
Allergan plc
AGN
| – | – |
-64,300
| Closed | -$10.8M |
|